Division of Pulmonary and Critical Care, School of Medicine, Johns Hopkins University, Baltimore, Md.
Department of Medicine and Lung Institute, College of Health Sciences, Makerere University, Kampala, Uganda.
J Allergy Clin Immunol Pract. 2018 Sep-Oct;6(5):1580-1587.e2. doi: 10.1016/j.jaip.2017.11.032. Epub 2018 Feb 1.
Allergic diseases are increasing in sub-Saharan Africa, but few studies have characterized the burden among adults.
We conducted a study to evaluate the prevalence and risk factors of allergic disorders in urban and rural Uganda.
We present a cross-sectional analysis of enrollment data from a population-based cohort study of adults aged ≥35 years in urban and rural Uganda. Sociodemographic and both lifetime and 12-month respiratory symptoms data were collected and spirometry was conducted following standard guidelines.
In 1,308 adults (median age 43.8 years and 52.3% female), we found an age-adjusted prevalence of 6.8% for asthma (9.8% urban, 4.3% rural; P < .001), 11.9% for allergic rhinitis (16.4% urban, 7.8% rural; P < .001), and 8.2% for eczema (9.9% urban, 7.8% rural; P = .15). Urbanization was the primary driver of asthma, accounting for 61.4% of cases (95% confidence interval [CI] 22.0% to 83.4%), and was the strongest risk factor for any allergic illness (odds ratio [OR] = 1.87, 95% CI 1.39-2.51). Parental asthma was not associated with allergic illness. Asthma was associated with a lower forced expiratory volume in 1 second (FEV) by 0.56 z scores (95% CI 0.33-0.80). We found a dose-response association between lower quintiles of the FEV/forced vital capacity ratio and both hospitalization (OR = 1.77, 95% CI 1.21-2.59) and impairment in daily activities (1.65, 1.20-2.27).
Asthma and allergic rhinitis were twice as prevalent in urban settings. Asthma was associated with greater impairment and worse lung function outcomes. We identified a high prevalence of allergic disorders in Uganda, which can be expected to increase due to urbanization and resultant exposures throughout early development.
过敏疾病在撒哈拉以南非洲呈上升趋势,但很少有研究描述成年人的疾病负担。
我们进行了一项研究,以评估乌干达城乡地区过敏疾病的患病率和危险因素。
我们对乌干达城乡地区年龄≥35 岁的成年人进行了一项基于人群的队列研究,对其入组数据进行了横断面分析。收集了社会人口学、终生和 12 个月呼吸系统症状数据,并按照标准指南进行了肺功能测定。
在 1308 名成年人(中位年龄 43.8 岁,52.3%为女性)中,我们发现哮喘的年龄调整患病率为 6.8%(城市为 9.8%,农村为 4.3%;P<.001),过敏性鼻炎为 11.9%(城市为 16.4%,农村为 7.8%;P<.001),特应性皮炎为 8.2%(城市为 9.9%,农村为 7.8%;P=0.15)。城市化是哮喘的主要驱动因素,占病例的 61.4%(95%置信区间 [CI] 22.0%至 83.4%),也是任何过敏疾病的最强危险因素(比值比 [OR] 1.87,95% CI 1.39 至 2.51)。父母哮喘与过敏疾病无关。哮喘与用力呼气量第一秒(FEV)降低 0.56 z 评分相关(95% CI 0.33 至 0.80)。我们发现,用力肺活量/用力肺活量比值的五分位越低,与住院(OR 1.77,95% CI 1.21 至 2.59)和日常活动受损(1.65,1.20 至 2.27)的关联越强。
哮喘和过敏性鼻炎在城市环境中更为常见。哮喘与更大的损害和更差的肺功能结果相关。我们发现乌干达过敏疾病的患病率很高,由于城市化和早期发育过程中由此产生的暴露,预计这一患病率将会增加。